The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized clinical trial on resection of the primary tumor versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases.
 
Nuh N. Rahbari
No Relationships to Disclose
 
Sebastiano Biondo
No Relationships to Disclose
 
Manuel Feißt
No Relationships to Disclose
 
Thomas Bruckner
No Relationships to Disclose
 
Inga Rossion
No Relationships to Disclose
 
Steffen Luntz
No Relationships to Disclose
 
Ulrich Bork
No Relationships to Disclose
 
Markus W. Büchler
No Relationships to Disclose
 
Gunnar Folprecht
Honoraria - Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Mundipharma; Roche/Genentech; Sanofi/Aventis; SERVIER
Research Funding - Merck KGaA
 
Meinhard Kieser
No Relationships to Disclose
 
Florian Lordick
Honoraria - Art Tempi; AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Incyte; Lilly; Medscape; Medupdate; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER; Streamedup!
Consulting or Advisory Role - Amgen; Astellas Pharma; Beigene; Bristol-Myers Squibb; Daichi Sankyo; Lilly; Merck Sharp & Dohme; Novartis; SERVIER; Zymeworks
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Juergen Weitz
No Relationships to Disclose